Publications by ESiOR personnel

Our experts have written, co-written, and provided insights into hundreds of publications.

  • ESiOR author

  • Type of publication

  • Year

  • Language

  • Reset

Pulmonary Arterial Hypertension (PAH) and Chronic Thromboembolic Pulmonary Hypertension (CTEPH) Patients in Finland (FINPAH) – A Descriptive Retrospective Real World Cohort Study Between 2008 and 2020

Pentikäinen M, Soini E, Asseburg C, Mankinen P, et al. Pulmonary Arterial Hypertension (PAH) and Chronic Thromboembolic Pulmonary Hypertension (CTEPH) Patients in Finland (FINPAH) – A Descriptive Retrospective Real World Cohort Study Between 2008 and 2020. Value Health 2022;25:12S.

Comparison of Certified Secure Processing Environments (SPE) – Novel Platforms for Collection, Augmentation, Structuring, Transfer, Management, Analysis, Sharing, Reporting, and Storage of Sensitive Data?

Soini E, Hallinen T, Martikainen J. Comparison of Certified Secure Processing Environments (SPE) – Novel Platforms for Collection, Augmentation, Structuring, Transfer, Management, Analysis, Sharing, Reporting, and Storage of Sensitive Data? Value Health 2022;25:12S.

Health economic evaluation of gravity-based intravenous infusions in Finland: Digital remote monitoring frees capacity and saves materials

Not available online

Puolitaival A, Savola M, Tuomainen P, Asseburg C, Lundström T, Soini E. Health economic evaluation of gravity-based intravenous infusions in Finland: Digital remote monitoring frees capacity and saves materials. WoCoVa 2022; Podium B11.4.

Faster Access to Innovative Therapies with Risk-Sharing Agreements – Cancer Medication Reimbursement Decisions from January 2012 to November 2021 in Finland

Ihalmo P, Väätäinen S, Soini E, Vandorou C, Mankinen P, Nevalainen E, Price M. Faster Access to Innovative Therapies with Risk-Sharing Agreements - Cancer Medication Reimbursement Decisions from January 2012 to November 2021 in Finland. Value Health 2022;25:6 S1.

Real-world effectiveness of digital and group-based lifestyle interventions as compared with usual care to reduce type 2 diabetes risk – A stop diabetes pragmatic randomised trial

Lakka TA, Aittola K, Järvelä-Reijonen E, Tilles-Tirkkonen T, Männikkö R, Lintu N, Karhunen L, Kolehmainen M, Harjumaa M, Mattila E, Järvenpää R, Ermes M, Mikkonen S, Martikainen J, et al. Real-world effectiveness of digital and group-based lifestyle interventions as compared with usual care to reduce type 2 diabetes risk - A stop diabetes pragmatic randomised trial. Lancet Reg Health Eur 2023;24:100527.

Back to top